Other drugs do what Pfizer's aimed to do
(AP)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20061205/ap_on_he_me/cholesterol_drug_consumers"><img src="http://d.yimg.com/us.yimg.com/p/ap/20061203/capt.38d447629ac54e6a98bcbd09e3a273ad.pfizer_cholesterol_drug_ny111.jpg?x=130&y=84&sig=z7aDhCPqHOHbW20izx.pwg--" align="left" height="84" width="130" alt="The world headquarters of Pfizer Inc. is seen in New York in this April 12, 2005 file photo. Pfizer has cut off all clinical trials and development for a cholesterol drug that was supposed to be the star of its pipeline because of an unexpected number of deaths and cardiovascular problems in patients who used it, the company said Saturday, Dec. 2, 2006. (AP Photo/Mark Lennihan)" border="0" /></a>AP - Pfizer Inc.'s new experimental heart drug is dead, but the dual approach the company was testing — boosting good cholesterol while lowering the bad — is very much alive, specialists said Monday.</p><br clear="all"/>